(19)
(11) EP 1 517 917 A2

(12)

(88) Date of publication A3:
27.01.2005

(43) Date of publication:
30.03.2005 Bulletin 2005/13

(21) Application number: 01995166.4

(22) Date of filing: 16.11.2001
(51) International Patent Classification (IPC)7C07K 14/435
(86) International application number:
PCT/US2001/043490
(87) International publication number:
WO 2002/042417 (30.05.2002 Gazette 2002/22)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

(30) Priority: 20.11.2000 US 249981 P

(71) Applicant: Merck & Co., Inc.
Rahway,New Jersey 07065-0907 (US)

(72) Inventors:
  • FOLANDER, Kimberly, L.
    Rahway, NJ 07065-0907 (US)
  • MCKENNA, Edward, J.
    Rahway, NJ 07065-0907 (US)
  • SWANSON, Richard, J.
    Rahway, NJ 07065-0907 (US)
  • LIU, Yuan
    Rahway, NJ 07065-0907 (US)

(74) Representative: Horgan, James Michael Frederic et al
Merck & Co., Inc.European Patent DepartmentTerlings ParkEastwick Road
Harlow, Essex CM20 2QR
Harlow, Essex CM20 2QR (GB)

   


(54) HUMAN ERG2 POTASSIUM CHANNEL